Paul Alloway, PhD, JD
Vice President and Head of Legal
Paul Alloway, PhD, JD, is the vice president and head of legal at Foghorn Therapeutics. Paul, a US-registered patent attorney, brings 18 years of leadership and legal experience acquired from working in the biotechnology industry, private equity and private practice.
Before joining Foghorn, Paul was Vice President & Senior Counsel at DRI Capital, Inc., a private-equity firm that specializes in pharmaceutical healthcare royalty investments, where he oversaw a team that was responsible for conducting patent, regulatory and legal due diligence, drafting and negotiating agreements, conducting financings and securitizations, and overseeing litigation and governance matters. Prior to joining DRI, Paul spent 9 years as a patent attorney at Alexion and Genzyme, where he supervised and managed a team responsible for IP Operations, and provided broad-based legal and IP-related support for numerous commercial, clinical and preclinical products. Paul began his career at an IP boutique firm, where he prepared and prosecuted patent applications in a wide range of technologies, including biotechnology, pharmaceuticals and medical devices.
Paul obtained his BSc from the University of Toronto, his PhD in molecular and cellular biology from Dartmouth College and his JD from Suffolk University Law School.